Lv51
1600 积分 2021-06-24 加入
Targeting FXR in Cholestasis
4个月前
已完结
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
4个月前
已完结
Bile acid signaling in metabolic and inflammatory diseases and drug development
6个月前
已完结
Bile salts in control of lipid metabolism
6个月前
已完结
Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia
7个月前
已完结
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
7个月前
已完结
Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury
7个月前
已完结
Drug-induced liver injury
7个月前
已完结
Non-alcoholic fatty liver disease and dyslipidemia: An update
7个月前
已完结
乙型病毒性肝炎全人群管理专家共识
10个月前
已完结
皖公网安备34019202002308
